RETRACTED: Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways (Retracted Article)

被引:64
作者
Bischof, O [1 ]
Nacerddine, K [1 ]
Dejean, A [1 ]
机构
[1] Inst Pasteur, INSERM, U579, Nucl Org & Oncogenesis Unit, F-75724 Paris 15, France
关键词
D O I
10.1128/MCB.25.3.1013-1024.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular senescence can be triggered by a variety of signals. including loss of telomeric integrity or intense oncogenic signaling, and is considered a potent, natural tumor suppressor mechanism. Previously, it was shown that the promyelocytic leukemia protein (PML) induces cellular senescence when overexpressed in primary human fibroblasts. The mechanism by which the PML W isoform elicits this irreversible growth arrest is believed to involve activation of the tumor suppressor pathways p21/p53 and p16/Rb: however. a requirement for either pathway has not been demonstrated unequivocally. To investigate the individual contributions of p53 and Rb to PML-induced senescence, we used oncoproteins E6 and E7 from human papillomaviruses (HPVs). which predominantly target p53 and Rb. We show that E7, but not E6, circumvents PML-induced senescence. Using different E7 mutant proteins, dominant negative cyclin-dependent kinase 4, and p16 RNA interference. we demonstrate that Rb-related and Rb-independent mechanisms of E7 are necessary for subversion of PML-induced senescence and we identify PML as a novel target for E7. Interaction between E7 and a functional prosenescence complex composed of PML, p53, and CBP perturbs transcriptional activation of p53. thus highlighting a significant effect also on the p53 tumor suppressor pathway. Given the importance of HPV in the pathogenesis of cervical cancer, our results warrant a more detailed analyses of PML in HPV infections.
引用
收藏
页码:1013 / 1024
页数:12
相关论文
共 66 条
  • [1] Post-translational modifications and activation of p53 by genotoxic stresses
    Appella, E
    Anderson, CW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2764 - 2772
  • [2] Interaction of the HPV E7 proteins with the pCAF acetyltransferase
    Avvakumov, N
    Torchia, J
    Mymryk, JS
    [J]. ONCOGENE, 2003, 22 (25) : 3833 - 3841
  • [3] BARTKOVA J, 1995, CANCER RES, V55, P949
  • [4] Interaction between the HPV E7 oneoprotein and the transcriptional coactivator p300
    Bernat, A
    Avvakumov, N
    Mymryk, JS
    Banks, L
    [J]. ONCOGENE, 2003, 22 (39) : 7871 - 7881
  • [5] Deconstructing PML-induced premature senescence
    Bischof, O
    Kirsh, O
    Pearson, M
    Itahana, K
    Pelicci, PG
    Dejean, A
    [J]. EMBO JOURNAL, 2002, 21 (13) : 3358 - 3369
  • [6] Boyer SN, 1996, CANCER RES, V56, P4620
  • [7] The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
    Brehm, A
    Nielsen, SJ
    Miska, EA
    McCance, DJ
    Reid, JL
    Bannister, AJ
    Kouzarides, T
    [J]. EMBO JOURNAL, 1999, 18 (09) : 2449 - 2458
  • [8] Tumor suppressors and oncogenes in cellular senescence
    Bringold, F
    Serrano, M
    [J]. EXPERIMENTAL GERONTOLOGY, 2000, 35 (03) : 317 - 329
  • [9] Cellular senescence as a tumor-suppressor mechanism
    Campisi, J
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (11) : S27 - S31
  • [10] Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
    Chelbi-Alix, MK
    Quignon, F
    Pelicano, L
    Koken, MHM
    De Thé, H
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (02) : 1043 - 1051